{"id":291270,"date":"2026-10-07T09:48:00","date_gmt":"2026-10-07T04:18:00","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=291270"},"modified":"2026-10-07T09:48:00","modified_gmt":"2026-10-07T04:18:00","slug":"why-tatva-chintan-pharma-chem-ltd-share-near-52-week-consecutive-high-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-tatva-chintan-pharma-chem-ltd-share-near-52-week-consecutive-high-2026\/","title":{"rendered":"Tatva Chintan Pharma Chem Ltd. (TATVA) 52 Week High Streak"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/tatva\/tatva-chintan-pharma-chem-ltd-share-price-today\">Tatva Chintan Pharma Chem Ltd. (TATVA)<\/a> share price is trading within 2% of its 52-week high today and stood at Rs 1,884.2, up 0% from the previous close. Market cap was Rs 4,187.88 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\"><strong><a href=\"https:\/\/univest.in\/stocks\/tatva\/tatva-chintan-pharma-chem-ltd-share-price-today\">Tatva Chintan Pharma Chem Ltd.<\/a> 52 Week High Streak<\/strong> has now run for the <strong>second straight session<\/strong>, with the stock trading within 2% of its 52-week high across the streak and advancing 5.24% over that span. The latest Univest data confirms the repeated-high pattern, but it does not establish a company-specific catalyst behind the move. As of 07 October 2026 at 9:22 AM IST, TATVA was trading at Rs 1,884.2, keeping it near the upper end of its yearly range.<\/p>\n<p style=\"margin-top:0!important;\">The latest trade compared with a previous close of Rs 1,884.15, while the day opened at Rs 1,874.75 and moved between Rs 1,868.05 and Rs 1,898.25. Tatva Chintan Pharma Chem Ltd. has a market capitalisation of Rs 4,187.88 crore, which places the current <strong>Tatva Chintan Pharma Chem Ltd. 52 Week High Streak<\/strong> in the context of a company that is already trading close to its one-year peak rather than reacting to a single-session jump. For readers, the key signal is the persistence of the pattern across two sessions, not just the latest tick.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-tatva-chintan-pharma-chem-ltd-share-near-52-week-consecutive-high-2026\/#Tatva_Chintan_Pharma_Chem_Ltd_52_Week_High_Streak_Consecutive_High_Analysis\" title=\"Tatva Chintan Pharma Chem Ltd. 52 Week High Streak: Consecutive High Analysis\">Tatva Chintan Pharma Chem Ltd. 52 Week High Streak: Consecutive High Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-tatva-chintan-pharma-chem-ltd-share-near-52-week-consecutive-high-2026\/#What_the_Repeated_52-Week_Highs_Show\" title=\"What the Repeated 52-Week Highs Show\">What the Repeated 52-Week Highs Show<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-tatva-chintan-pharma-chem-ltd-share-near-52-week-consecutive-high-2026\/#Tatva_Chintan_Pharma_Chem_Ltd_TATVA_Fundamental_Analysis\" title=\"Tatva Chintan Pharma Chem Ltd. (TATVA) Fundamental Analysis\">Tatva Chintan Pharma Chem Ltd. (TATVA) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-tatva-chintan-pharma-chem-ltd-share-near-52-week-consecutive-high-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-tatva-chintan-pharma-chem-ltd-share-near-52-week-consecutive-high-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-tatva-chintan-pharma-chem-ltd-share-near-52-week-consecutive-high-2026\/#Why_Investors_Are_Watching_Tatva_Chintan_Pharma_Chem_Ltd\" title=\"Why Investors Are Watching Tatva Chintan Pharma Chem Ltd.\">Why Investors Are Watching Tatva Chintan Pharma Chem Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-tatva-chintan-pharma-chem-ltd-share-near-52-week-consecutive-high-2026\/#About_Tatva_Chintan_Pharma_Chem_Ltd\" title=\"About Tatva Chintan Pharma Chem Ltd.\">About Tatva Chintan Pharma Chem Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-tatva-chintan-pharma-chem-ltd-share-near-52-week-consecutive-high-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-tatva-chintan-pharma-chem-ltd-share-near-52-week-consecutive-high-2026\/#What_does_Tatva_Chintan_Pharma_Chem_Ltd_52_Week_High_Streak_mean\" title=\"What does Tatva Chintan Pharma Chem Ltd. 52 Week High Streak mean?\">What does Tatva Chintan Pharma Chem Ltd. 52 Week High Streak mean?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-tatva-chintan-pharma-chem-ltd-share-near-52-week-consecutive-high-2026\/#How_many_sessions_has_TATVA_stayed_near_its_52-week_high\" title=\"How many sessions has TATVA stayed near its 52-week high?\">How many sessions has TATVA stayed near its 52-week high?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-tatva-chintan-pharma-chem-ltd-share-near-52-week-consecutive-high-2026\/#How_much_has_Tatva_Chintan_Pharma_Chem_Ltd_moved_across_the_streak\" title=\"How much has Tatva Chintan Pharma Chem Ltd. moved across the streak?\">How much has Tatva Chintan Pharma Chem Ltd. moved across the streak?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-tatva-chintan-pharma-chem-ltd-share-near-52-week-consecutive-high-2026\/#Has_a_company-specific_catalyst_been_confirmed\" title=\"Has a company-specific catalyst been confirmed?\">Has a company-specific catalyst been confirmed?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-tatva-chintan-pharma-chem-ltd-share-near-52-week-consecutive-high-2026\/#Is_Tatva_Chintan_Pharma_Chem_Ltd_expensive_compared_with_peers\" title=\"Is Tatva Chintan Pharma Chem Ltd. expensive compared with peers?\">Is Tatva Chintan Pharma Chem Ltd. expensive compared with peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-tatva-chintan-pharma-chem-ltd-share-near-52-week-consecutive-high-2026\/#What_do_the_latest_fundamentals_show\" title=\"What do the latest fundamentals show?\">What do the latest fundamentals show?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-tatva-chintan-pharma-chem-ltd-share-near-52-week-consecutive-high-2026\/#Why_is_the_market_capitalisation_important_here\" title=\"Why is the market capitalisation important here?\">Why is the market capitalisation important here?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-tatva-chintan-pharma-chem-ltd-share-near-52-week-consecutive-high-2026\/#What_should_investors_monitor_next\" title=\"What should investors monitor next?\">What should investors monitor next?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-tatva-chintan-pharma-chem-ltd-share-near-52-week-consecutive-high-2026\/#Track_Tatva_Chintan_Pharma_Chem_Ltd_TATVA_Share_Price_on_Univest\" title=\"Track Tatva Chintan Pharma Chem Ltd. (TATVA) Share Price on Univest\">Track Tatva Chintan Pharma Chem Ltd. (TATVA) Share Price on Univest<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Tatva_Chintan_Pharma_Chem_Ltd_52_Week_High_Streak_Consecutive_High_Analysis\"><\/span><strong>Tatva Chintan Pharma Chem Ltd. 52 Week High Streak: Consecutive High Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,884.2<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,884.15<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 0.05 (+0%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,874.75<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,898.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,868.05<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4,187.88 crore<\/td>\n<\/tr>\n<\/table>\n<p>Tatva Chintan Pharma Chem Ltd. (TATVA) traded at Rs 1,884.2 versus the previous close of Rs 1,884.15, a rise of 0%. The stock opened at Rs 1,874.75, reached a high of Rs 1,898.25 and touched a low of Rs 1,868.05.<\/p>\n<p>Tatva Chintan Pharma Chem Ltd. share price today was almost unchanged from the previous close, with TATVA last traded at Rs 1,884.2 against Rs 1,884.15 yesterday. The intraday range stayed contained between Rs 1,868.05 and Rs 1,898.25, and the stock spent the morning near the upper part of that band. That keeps <strong>Tatva Chintan Pharma Chem Ltd. 52 Week High Streak<\/strong> relevant for readers tracking whether the near-high trade is holding or fading.<\/p>\n<p>From a market-capitalisation lens, the company remains a Rs 4,187.88 crore business, so the price action is important mainly because it keeps the stock close to its yearly peak for a second straight session. The repeated trade near the top of the 52-week range can matter more than a one-day uptick because it shows that the stock is staying in the same price zone across consecutive sessions. For stock market readers searching for <strong>Tatva Chintan Pharma Chem Ltd. Share Price<\/strong>, this is a straightforward update: the move has been steady, the range has been tight, and the stock continues to trade near its 52-week high.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_the_Repeated_52-Week_Highs_Show\"><\/span><strong>What the Repeated 52-Week Highs Show<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The latest <strong>Tatva Chintan Pharma Chem Ltd. 52 Week High Streak<\/strong> shows persistence rather than a one-off move. A second straight session near the yearly high tells readers that the stock has remained in a tight area across two trading days, with a cumulative gain of 5.24% over the streak. That is the key differentiator versus a single-day breakout article.<\/p>\n<p>There is no company-specific catalyst confirmed by the latest Univest data, so the repeated near-high trade should be read as a price pattern first and a story second. For investors tracking <strong>Tatva Chintan Pharma Chem Ltd. Stock News<\/strong>, the main point is that the market has continued to value the shares near their one-year peak. The latest move also keeps the stock in the broader set of <strong>Stocks Hitting 52 Week Highs<\/strong> and <strong>Stocks At One Year High Today<\/strong>, which often attracts attention from readers scanning <strong>Stocks In News Today<\/strong> and <strong>Top Gainers This Week<\/strong>.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Tatva_Chintan_Pharma_Chem_Ltd_TATVA_Fundamental_Analysis\"><\/span><strong>Tatva Chintan Pharma Chem Ltd. (TATVA) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4,187.88 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">85.77x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">5.52x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">5.53%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">7.17%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 21.97<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 341.03<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.11%<\/td>\n<\/tr>\n<\/table>\n<p>Tatva Chintan Pharma Chem Ltd. (TATVA) fundamental metrics show P\/E 85.77x, P\/B 5.52x, ROE 5.53%, ROCE 7.17%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Tatva Chintan Pharma Chem Ltd. has a market capitalisation of Rs 4,187.88 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 85.77x, P\/B at 5.52x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 5.53% and ROCE of 7.17%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 21.97, book value per share of Rs 341.03, dividend yield of 0.11%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 22.21x, median ROE of 7.87%, median ROCE of 10.04%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Chemicals<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Chemicals<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">85.77x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">22.21x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">43.25x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 742.21x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">5.52x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.92x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">5.53%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">7.87%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">7.17%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.04%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4,187.88 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 483.38 crore<\/td>\n<\/tr>\n<\/table>\n<p>Tatva Chintan Pharma Chem Ltd. (TATVA) is classified under sector: Chemicals and industry: Chemicals.<\/p>\n<p>Tatva Chintan Pharma Chem Ltd. (TATVA) has a P\/E ratio of 85.77x, which is above the benchmark median of 22.21x, a difference of +286.18%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Tatva Chintan Pharma Chem Ltd. (TATVA) has a ROE of 5.53%, which is below the benchmark median of 7.87%, a difference of -29.73%. Tatva Chintan Pharma Chem Ltd. (TATVA) has a ROCE of 7.17%, which is below the benchmark median of 10.04%, a difference of -28.59%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/vishnu\/vishnu-chemicals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Vishnu Chemicals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">VISHNU<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,359<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">31.23<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.26<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.38<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/epigral\/epigral-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Epigral Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">EPIGRAL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,390.28<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.52<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.93<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.09<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.65<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/gujalkali\/gujarat-alkalies-and-chemicals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Gujarat Alkalies And Chemicals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">GUJALKALI<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,442.93<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">68.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0.86<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.04<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.4<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/grauweil\/grauer-and-weil-(india)-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Grauer &amp; Weil (India) Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">GRAUWEIL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3,782.36<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">23.3<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.33<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.23<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.55<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/fosecoind\/foseco-india-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Foseco India Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">FOSECOIND<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,728.42<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">67.27<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.51<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.87<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.35<\/td>\n<\/tr>\n<\/table>\n<p>Tatva Chintan Pharma Chem Ltd. (TATVA) has a P\/E ratio of 85.77x compared with the displayed peer median of 31.23x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 5.53% compares with a peer median of 14.26% across the companies shown in the table. ROCE stood at 7.17% versus the displayed peer median of 15.65%, providing a capital-efficiency comparison. Tatva Chintan Pharma Chem Ltd. (TATVA) has a market capitalisation of Rs 4,187.88 crore. Among the 5 peers shown, 4 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Tatva_Chintan_Pharma_Chem_Ltd\"><\/span><strong>Why Investors Are Watching Tatva Chintan Pharma Chem Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Tatva Chintan Pharma Chem Ltd. 52 Week High Streak has continued for a second straight session, keeping the stock near its yearly peak.<\/li>\n<li>The cumulative move across the streak is 5.24%, which is the main difference versus a single-day move in Tatva Chintan Pharma Chem Ltd. Share Price.<\/li>\n<li>The latest Univest figures confirm the repeated near-high price pattern, but no company-specific catalyst is established.<\/li>\n<li>Tatva Chintan Pharma Chem Ltd. Fundamental Analysis shows a high valuation compared with the chemicals peer median.<\/li>\n<li>The stock remains one of the more closely watched 52 Week High Stocks in the chemicals space.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Tatva_Chintan_Pharma_Chem_Ltd\"><\/span><strong>About Tatva Chintan Pharma Chem Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Tatva Chintan Pharma Chem Ltd. operates in the chemicals industry and is listed on the NSE and BSE under the symbol TATVA. The company\u2019s current market capitalisation is Rs 4,187.88 crore, placing it above the typical size of many names in the same industry. Its recent <strong>Tatva Chintan Pharma Chem Ltd. 52 Week High Streak<\/strong> has drawn attention because the stock continues to trade close to its one-year high while the broader market watches valuation, return ratios and peer positioning. For readers tracking <strong>Tatva Chintan Pharma Chem Ltd. Stock News<\/strong>, the company now sits at an important market-visible point.<\/p>\n<p>In the chemicals space, Tatva Chintan Pharma Chem Ltd. remains a stock where <strong>Tatva Chintan Pharma Chem Ltd. Share Price Today<\/strong>, valuation metrics and sector comparison all matter together. The company\u2019s P\/E, P\/B, ROE, ROCE, EPS and book value create the financial context, while the repeated near-high trade keeps it firmly on watch for market participants scanning <strong>Tatva Chintan Pharma Chem Ltd. Stock Analysis<\/strong> and <strong>Tatva Chintan Pharma Chem Ltd. Share Price Update<\/strong>.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_does_Tatva_Chintan_Pharma_Chem_Ltd_52_Week_High_Streak_mean\"><\/span><strong>What does Tatva Chintan Pharma Chem Ltd. 52 Week High Streak mean?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> It means Tatva Chintan Pharma Chem Ltd. has traded within 2% of its 52-week high for a second straight session. The pattern shows the stock has stayed near its yearly peak across consecutive sessions rather than just touching that zone once.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_many_sessions_has_TATVA_stayed_near_its_52-week_high\"><\/span><strong>How many sessions has TATVA stayed near its 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> According to latest Univest data, the streak is two sessions long. The article uses the second straight session label, which confirms repeated near-high trading across back-to-back sessions. The stock moved 0% so far today.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_has_Tatva_Chintan_Pharma_Chem_Ltd_moved_across_the_streak\"><\/span><strong>How much has Tatva Chintan Pharma Chem Ltd. moved across the streak?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The cumulative move across the streak is 5.24%. That figure captures the full near-high run and is more informative than looking only at the latest price change.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Has_a_company-specific_catalyst_been_confirmed\"><\/span><strong>Has a company-specific catalyst been confirmed?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. The latest Univest data confirms the repeated near-high price pattern, but it does not establish a company-specific reason for the move. Readers should treat the price behaviour as confirmed, while the cause remains unconfirmed.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Tatva_Chintan_Pharma_Chem_Ltd_expensive_compared_with_peers\"><\/span><strong>Is Tatva Chintan Pharma Chem Ltd. expensive compared with peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> On the numbers given, the stock trades at a higher P\/E and P\/B than the peer median for chemicals. That places it above the middle of the pack on valuation, even though some peers trade on similarly rich multiples.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_the_latest_fundamentals_show\"><\/span><strong>What do the latest fundamentals show?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The company\u2019s P\/E is 85.77, P\/B is 5.52, ROE is 5.53 and ROCE is 7.17. EPS stands at Rs 21.97 and book value at Rs 341.03, giving investors a full valuation and return-ratio snapshot.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_the_market_capitalisation_important_here\"><\/span><strong>Why is the market capitalisation important here?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Market capitalisation helps frame the stock\u2019s size and how the market values the company. Tatva Chintan Pharma Chem Ltd. is valued at Rs 4,187.88 crore, which puts the near-high move into a broader company-size context.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_monitor_next\"><\/span><strong>What should investors monitor next?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should track whether Tatva Chintan Pharma Chem Ltd. continues to trade near its yearly peak, whether fundamentals support the valuation premium, and whether any fresh company update changes the price pattern. The current streak remains a market signal, not a recommendation.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What does Tatva Chintan Pharma Chem Ltd. 52 Week High Streak mean?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"It means Tatva Chintan Pharma Chem Ltd. has traded within 2% of its 52-week high for a second straight session. The pattern shows the stock has stayed near its yearly peak across consecutive sessions rather than just touching that zone once.\"}},{\"@type\":\"Question\",\"name\":\"How many sessions has TATVA stayed near its 52-week high?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"According to latest Univest data, the streak is two sessions long. The article uses the second straight session label, which confirms repeated near-high trading across back-to-back sessions. The stock moved 0% so far today.\"}},{\"@type\":\"Question\",\"name\":\"How much has Tatva Chintan Pharma Chem Ltd. moved across the streak?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The cumulative move across the streak is 5.24%. That figure captures the full near-high run and is more informative than looking only at the latest price change.\"}},{\"@type\":\"Question\",\"name\":\"Has a company-specific catalyst been confirmed?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. The latest Univest data confirms the repeated near-high price pattern, but it does not establish a company-specific reason for the move. Readers should treat the price behaviour as confirmed, while the cause remains unconfirmed.\"}},{\"@type\":\"Question\",\"name\":\"Is Tatva Chintan Pharma Chem Ltd. expensive compared with peers?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"On the numbers given, the stock trades at a higher P\/E and P\/B than the peer median for chemicals. That places it above the middle of the pack on valuation, even though some peers trade on similarly rich multiples.\"}},{\"@type\":\"Question\",\"name\":\"What do the latest fundamentals show?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The company\u2019s P\/E is 85.77, P\/B is 5.52, ROE is 5.53 and ROCE is 7.17. EPS stands at Rs 21.97 and book value at Rs 341.03, giving investors a full valuation and return-ratio snapshot.\"}},{\"@type\":\"Question\",\"name\":\"Why is the market capitalisation important here?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Market capitalisation helps frame the stock\u2019s size and how the market values the company. Tatva Chintan Pharma Chem Ltd. is valued at Rs 4,187.88 crore, which puts the near-high move into a broader company-size context.\"}},{\"@type\":\"Question\",\"name\":\"What should investors monitor next?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors should track whether Tatva Chintan Pharma Chem Ltd. continues to trade near its yearly peak, whether fundamentals support the valuation premium, and whether any fresh company update changes the price pattern. The current streak remains a market signal, not a recommendation.\"}}]}<\/script><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Track_Tatva_Chintan_Pharma_Chem_Ltd_TATVA_Share_Price_on_Univest\"><\/span><strong>Track Tatva Chintan Pharma Chem Ltd. (TATVA) Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/tatva\/tatva-chintan-pharma-chem-ltd-share-price-today\">Tatva Chintan Pharma Chem Ltd. (TATVA) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Tatva Chintan Pharma Chem Ltd. Share Price trades near its 52-week high at Rs 1,884.2, marking a 0% rise today. Market cap stands at Rs 4,187.88 crore.<\/p>\n","protected":false},"author":38,"featured_media":291269,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-291270","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["291269"],"rank_math_title":["Tatva Chintan Pharma Chem Ltd. near 52-week high streak"],"rank_math_description":["Tatva Chintan Pharma Chem Ltd. has traded near its 52-week high for a second straight session. See the streak move, valuation and sector context."],"rank_math_focus_keyword":["Tatva Chintan Pharma Chem Ltd. 52 Week High Streak"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/tatva-chintan-pharma-chem-ltd-tatva-52-week-high-streak.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/291270","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=291270"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/291270\/revisions"}],"predecessor-version":[{"id":291271,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/291270\/revisions\/291271"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/291269"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=291270"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=291270"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=291270"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}